Formulations comprising entrapped active ingredients and uses thereof

Details for Australian Patent Application No. 2002255993 (hide)

Owner The Scripps Research Institute Optimer Pharmaceuticals

Inventors Hwang, San-Bao; Lotz, Martin; Shikhman, Alexander R.; Hu, Changyong

Agent Griffith Hack

Pub. Number AU-B-2002255993

PCT Pub. Number WO2002/078445

Priority 60/280,351 29.03.01 US

Filing date 29 March 2002

Wipo publication date 15 October 2002

Acceptance publication date 1 May 2008

International Classifications

A61K 9/127 (2006.01) Medicinal preparations characterised by special physical form - Liposomes

A61K 31/7008 (2006.01) - Compounds having an amino group directly attached to a carbon atom of the saccharide radical, e.g. D-galactosamine, ranimustine

A61K 31/726 (2006.01) - Glycosaminoglycans, i.e. mucopolysaccharides

A61K 47/24 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - containing atoms other than carbon, hydrogen, halogen, oxygen, nitrogen or sulfur

A61K 47/34 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds

A61K 47/36 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Polysaccharides

A61K 47/48 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates

A61P 19/00 (2006.01) Drugs for skeletal disorders

A61P 19/02 (2006.01) Drugs for skeletal disorders

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

A61K 9/16 (2006.01) Medicinal preparations characterised by special physical form - Agglomerates

A61K 9/51 (2006.01) Medicinal preparations characterised by special physical form - Nanocapsules

Event Publications

3 April 2003 Application Open to Public Inspection

  Published as AU-B-2002255993

1 May 2008 Application Accepted

  Published as AU-B-2002255993

28 August 2008 Standard Patent Sealed

27 October 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002255994-TRANSGENIC MICE CONTAINING GPR31 GENE DISRUPTIONS

2002255992-ELECTRONIC SHIPPING SYSTEM FOR PACKAGE PICKUP AND ANYWHERE TO ANYWHERE DELIVERY